Добро пожаловать
Нажатие «Авторизоваться» означает, что вы соглашаетесь с Условия использования и политика конфиденциальности Cointime.
Зарегистрировать аккаунт
Аккаунт уже существует?
Нажатие «page.Sign up» означает, что вы соглашаетесь с <a class="underline" href="#term-of-service">Условия использования</a> и a class="underline" href="#privacy-policy">политика конфиденциальности</a> Cointime.
Войдите, используя email
Зарегистрируйтесь с помощью email
твой почтовый ящик
Проверь свои входящие
Нажмите на ссылку в , чтобы войти.
Нажмите на ссылку в , чтобы зарегистрироваться.
MOgene
company
About
MOgene is a provider of genomics services for academic, government, and industrial research groups and institutions.
- 11 - 50
Details
- Last Funding Type
- Grant
- Last Funding Money Raised
- $150K
- Industries
- Biotechnology,Genetics,Government,Information Technology
- Founded date
- Feb 1, 2004
- Number Of Employee
- 11 - 50
- Operating Status
- Active
MOgene LC, a Limited Liability Company has been in operations since February 2004. The company has established solid reputation as a genomics service provider to academic, government and industrial research groups and institutions. Several papers have been published in leading scientific journals, based on the genomic services provided by MOgene. Company’s management and employees have a vast range of expertise and experience.
Funding Rounds
Number of Funding Rounds
Total Funding Amount
1
$150K
MOgene has raised a total of
$150K
in funding over 2 rounds. Their latest funding was raised on
Jun 1, 2012 from a Grant round.
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| Jun 1, 2012 | Grant | $150K | 1 |
National Science Foundation
|
— | Detail |
Investors
Number of Lead Investors
Number of Investors
1
1
MOgene is funded by 1 investors.
National Science Foundation
are the most recent investors.
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
|
National Science Foundation
|
Yes | Grant |
Share
Twitter
LinkedIn
Line
Facebook
Telegram
Email
Page Link
